Skip to content

Drug interactions

Donepezil + Umeclidinium-vilanterol

Severity: Moderate

Donepezil and Umeclidinium-vilanterol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Donepezil can prolong the QT interval and cause bradycardia, and vilanterol, a beta-2 agonist, may also affect QT and heart rate at higher exposures. Additionally, donepezil's cholinergic action opposes the antimuscarinic effect of umeclidinium, which could reduce its bronchodilator benefit. Clinically significant effects are uncommon at usual doses.

What this interaction means in plain words

Donepezil and Umeclidinium-vilanterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Donepezil belongs to Central Nervous System; Umeclidinium-vilanterol belongs to Respiratory.

Evidence level: Low

Why it happens

Additive effects on cardiac repolarization plus pharmacodynamic opposition between cholinesterase inhibition and muscarinic blockade.

What to do

Monitor heart rate and ECG in patients with existing QT risk factors, bradycardia or conduction disease. Watch for reduced respiratory symptom control and review whether both agents are needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Donepezil and Umeclidinium-vilanterol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Donepezil with Umeclidinium-vilanterol?

MediHelp rates the interaction as moderate. Donepezil and Umeclidinium-vilanterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Donepezil can prolong the QT interval and cause bradycardia, and vilanterol, a beta-2 agonist, may also affect QT and heart rate at higher exposures. Additionally, donepezil's cholinergic action opposes the antimuscarinic effect of umeclidinium, which could reduce its bronchodilator benefit. Clinically significant effects are uncommon at usual doses.

How serious is the interaction between Donepezil and Umeclidinium-vilanterol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate and ECG in patients with existing QT risk factors, bradycardia or conduction disease. Watch for reduced respiratory symptom control and review whether both agents are needed.

What other medicines interact with Umeclidinium-vilanterol?

MediHelp also lists interactions of Umeclidinium-vilanterol with, for example, Aclidinium, Amiodarone, Amitriptyline. The full list is on the Umeclidinium-vilanterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in